Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by TechStocksRpt

C.FGFL

FGFL Exits Ethereum Holding for 1822% ROI netting $859,852

First Growth Funds Makes $859,852 Profit from Sale of Ethereum ACCESSWIRE /...

May 25, 2021

C.SPAI

EYEFI LAUNCHES SMART WASTE & DRAIN PRODUCT WITH FUJITSU

11/12/2020 8:14:00 AM - News Release EYEFI GROUP TECHNOLOGIES INC. - EYEFI...

December 11, 2020

C.FGFL

First Growth Funds Presentation Link

https://webfiles.thecse.com/sedar_filings/00048774/2012031447306995.pdf

December 10, 2020

C.SPAI

New Issue - Australian based Technology Company

From their press release; Eyefi Group Technologies Inc. is a software and...

December 10, 2020

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »